Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01992172 · ClinicalTrials.gov registry record · NA

Photocil (Topical) for the Treatment of Atopic Dermatitis

A NA study, sponsored by Applied Biology.

Completed
Registry status
NA
Development phase
7
Enrollment target

NCT01992172: Completed NA study, sponsored by Applied Biology.

NCT01992172 is a NA study that has completed, run by Applied Biology. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01992172, a NA study, has completed, sponsored by Applied Biology.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

Photocil is a topical drug (cream) that selectively delivers Narrow Band - Ultraviolet B (NB-UVB) therapy when exposed to sunlight. Photocil is intended to help protect users from non-therapeutic Ultraviolet B (UVB) radiation while selectively passing wavelengths of light in the NB-UVB range with peak transmission of 308nm. The aim of the study is to assess the safety and efficacy of Photocil in the treatment of atopic dermatitis.

Interventions

  • OTHER Placebo - Sunscreen (SPF 2)
  • DRUG Photocil for Atopic Dermatitis

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2013-08
Est. Completion 2014-12
Phase NA
Applied Biology

6 total trials

What the finished NCT01992172 record still lists

NCT01992172 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo - Sunscreen (SPF 2) is the first listed.

NCT01992172 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01992172 about?

NCT01992172 is a clinical study titled "Photocil (Topical) for the Treatment of Atopic Dermatitis". Photocil is a topical drug (cream) that selectively delivers Narrow Band - Ultraviolet B (NB-UVB) therapy when exposed to sunlight. Photocil is intended to help protect users from non-therapeutic Ultraviolet B (UVB) radiation while selectively passing wavelengths of light in the NB-UVB range with pe...

What is the current status of trial NCT01992172?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2013-08. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01992172?

The interventions under investigation include: Placebo - Sunscreen (SPF 2) (OTHER), Photocil for Atopic Dermatitis (DRUG).

Who is sponsoring clinical trial NCT01992172?

This trial is sponsored by Applied Biology, which has 6 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01992172's enrollment target sits among peer trials

7 1982nd of 2000 higher than 18 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01992172, the US trial registry maintained by the National Library of Medicine. NCT01992172 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.